Simvastatin and MBCD Inhibit Breast Cancer-Induced Osteoclast Activity by Targeting Osteoclastogenic Factors

References

• Waning DL, Guise TA. Molecular mechanisms of bone metastasis and associated muscle weakness. Clin Cancer Res 2014;20(12):3071–3077.
   PubMed Web of Science ®Google Scholar
• Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nat Rev Cancer 2011;11(6):411–425.
   PubMed Web of Science ®Google Scholar
• Eriksen EF. Cellular mechanisms of bone remodeling. Rev Endocr Metab Disord 2010;11(4):219–227.
   PubMed Web of Science ®Google Scholar
• Sethi N, Dai X, Winter CG, Kang Y. Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell 2011:19(2):192–205.
   PubMed Web of Science ®Google Scholar
• Mundy GR. Metastasis: metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2002;2(8):584–593.
   PubMed Web of Science ®Google Scholar
• Yoneda T, Hiraga T. Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem Biophys Res Commun 2005;328(3):679–687.
   PubMed Web of Science ®Google Scholar
• Yin JJ, Pollock CB, Kelly K. Mechanisms of cancer metastasis to the bone. Cell Res 2005;15(1):57–62.
   PubMed Web of Science ®Google Scholar
• Qian B-Z, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010;141(1):39–51.
   PubMed Web of Science ®Google Scholar
• Ghosh-Choudhury N, Mandal CC, Ghosh-Choudhury N, Choudhury GG. Simvastatin induces derepression of PTEN expression via NFκB to inhibit breast cancer cell growth. Cell Signal 2010;22(5):749–758.
   PubMed Web of Science ®Google Scholar
• Mandal CC, Ghosh-Choudhury N, Yoneda T, Choudhury GG, Ghosh-Choudhury N. Simvastatin prevents skeletal metastasis of breast cancer by an antagonistic interplay between p53 and CD44. J Biol Chem 2011;286(13):11314–11327.
   PubMed Web of Science ®Google Scholar
• Mandal CC, Rahman MM. Targeting intracellular cholesterol is a novel therapeutic strategy for cancer treatment. J Cancer Sci Ther 2014;6(12):510.
   PubMedGoogle Scholar
• Mandal CC. High cholesterol deteriorates bone health: new insights into molecular mechanisms. Front Endocrinol 2015;6:165. doi: 10.3389/fendo.2015.00165
   PubMed Web of Science ®Google Scholar
• Mandal CC, Sharma A, Panwar MS, Radosevich JA. Is cholesterol a mediator of cold-induced cancer? Tumor Biol 2016;37(7):9635–9648.
   PubMed Web of Science ®Google Scholar
• Ghosh-Choudhury N, Mandal CC, Choudhury GG. Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation. J Biol Chem 2007;282(7):4983–4993.
   PubMed Web of Science ®Google Scholar
• Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999;286(5446):1946–1949.
   PubMed Web of Science ®Google Scholar
• Babcook MA, Shukla S, Fu P, Vazquez EJ, Puchowicz MA, Molter JP, et al. Synergistic simvastatin and metformin combination chemotherapy for osseous metastatic castration-resistant prostate cancer. Mol Cancer Ther 2014;13(10):2288–2302.
   PubMed Web of Science ®Google Scholar
• Liu H, Wang Z, Li Y, Li W, Chen Y. Simvastatin prevents proliferation and bone metastases of lung adenocarcinoma in vitro and in vivo. Neoplasma 2012;60(3):240–246
   Web of Science ®Google Scholar
• Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 2002;3(6):889–901.
   PubMed Web of Science ®Google Scholar
• Sato K, Suematsu A, Nakashima T, Takemoto-Kimura S, Aoki K, Morishita Y, et al. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway. Nat Med 2006;12(12):1410–1416.
   PubMed Web of Science ®Google Scholar
• Ghosh-Choudhury N, Mandal CC, Das F, Ganapathy S, Ahuja S, Choudhury GG. c-Abl-dependent molecular circuitry involving Smad5 and phosphatidylinositol 3-kinase regulates bone morphogenetic protein-2-induced osteogenesis. J Biol Chem 2013;288(34):24503–24517.
   PubMed Web of Science ®Google Scholar
• Mandal CC, Ghosh Choudhury G, Ghosh-Choudhury N. Phosphatidylinositol 3 kinase/Akt signal relay cooperates with SMAD in bone morphogenetic protein-2-induced colony stimulating factor-1 (CSF-1) expression and osteoclast differentiation. Endocrinology 2009;150(11):4989–4998.
   PubMed Web of Science ®Google Scholar
• Kogawa M, Findlay DM, Anderson PH, Ormsby R, Vincent C, Morris HA, et al. Osteoclastic metabolism of 25 (OH)-vitamin D3: a potential mechanism for optimization of bone resorption. Endocrinology 2010;151(10):4613–4625.
   PubMed Web of Science ®Google Scholar
• Mandal CC, Drissi H, Choudhury GG, Ghosh-Choudhury N. Integration of phosphatidylinositol 3-kinase, Akt kinase, and Smad signaling pathway in BMP-2-induced osterix expression. Calcified Tissue Int 2010;87(6):533–540.
   PubMed Web of Science ®Google Scholar
• Mandal CC, Das F, Ganapathy S, Harris SE, Choudhury GG, Ghosh-Choudhury N. Bone morphogenetic protein-2 (BMP-2) activates NFATc1 transcription factor via an autoregulatory loop involving Smad/Akt/Ca2+ signaling. J Biol Chem 2016;291(3):1148–1161.
   PubMed Web of Science ®Google Scholar
• Mandal CC, Ganapathy S, Gorin Y, Mahadev K, Block K, Abboud HE, et al. Reactive oxygen species derived from Nox4 mediate BMP2 gene transcription and osteoblast differentiation. Biochem J 2011;433(2):393–402.
   PubMed Web of Science ®Google Scholar
• Mandal CC, Ghosh-Choudhury T, Dey N, Choudhury GG, Ghosh-Choudhury N. miR-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor CSF-1 expression. Carcinogenesis 2012;33(10):1897–1908. doi:10.1093/carcin/bgs198
   PubMed Web of Science ®Google Scholar
• Mikhailova M, Xu X, Robichaud TK, Pal S, Fields GB, Steffensen B. Identification of collagen binding domain residues that govern catalytic activities of matrix metalloproteinase-2 (MMP-2). Matrix Biol: J Int Soc Matrix Biol 2012;31(7–8):380–388. doi:10.1016/j.matbio.2012.10.001
   PubMed Web of Science ®Google Scholar
• Hanania R, Sun HS, Xu K, Pustylnik S, Jeganathan S, Harrison RE. Classically activated macrophages use stable microtubules for matrix metalloproteinase-9 (MMP-9) secretion. J Biol Chem 2012;287(11):8468–8483.
   PubMed Web of Science ®Google Scholar
• Mandal CC, Ganapathy S, Gorin Y, Mahadev K, Block K, Abboud HE, et al. Reactive oxygen species derived from Nox4 mediate BMP2 gene transcription and osteoblast differentiation. Biochem J 2011;433(2):393–402. doi:10.1042/BJ20100357
   PubMed Web of Science ®Google Scholar
• Mandal CC, Ghosh-Choudhury T, Dey N, Choudhury GG, Ghosh-Choudhury N. miR-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor CSF-1 expression. Carcinogenesis 2012;33(10):1897–1908. doi:10.1093/carcin/bgs198
   PubMed Web of Science ®Google Scholar
• Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKL–RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 2006;12(1):17–25.
   PubMed Web of Science ®Google Scholar
• Ghosh-Choudhury N, Singha PK, Woodruff K, St Clair P, Bsoul S, Werner SL, et al. Concerted action of Smad and CREB-binding protein regulates bone morphogenetic protein-2-stimulated osteoblastic colony-stimulating factor-1 expression. J Biol Chem 2006;281(29):20160–20170.
   PubMed Web of Science ®Google Scholar
• Balkan W, Martinez AF, Fernandez I, Rodriguez MA, Pang M, Troen BR. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand. Gene 2009;446(2):90–98.
   PubMed Web of Science ®Google Scholar
• Chiou W-F, Huang Y-L, Liu Y-W. (+)-Vitisin A inhibits osteoclast differentiation by preventing TRAF6 ubiquitination and TRAF6-TAK1 formation to suppress NFATc1 activation. PloS ONE 2014;9(2):e89159.
   PubMed Web of Science ®Google Scholar
• Luegmayr E, Glantschnig H, Wesolowski G, Gentile M, Fisher J, Rodan G, et al. Osteoclast formation, survival and morphology are highly dependent on exogenous cholesterol/lipoproteins. Cell Death Differ 2004;11:S108–S118.
   PubMed Web of Science ®Google Scholar
• Rubin J, Murphy TC, Rahnert J, Song H, Nanes MS, Greenfield EM, et al. Mechanical inhibition of RANKL expression is regulated by H-Ras-GTPase. J Biol Chem 2006;281(3):1412–1418.
   PubMed Web of Science ®Google Scholar
• Nakashima Y, Haneji T. Stimulation of osteoclast formation by RANKL requires interferon regulatory factor-4 and is inhibited by simvastatin in a mouse model of bone loss. PloS ONE 2013;8(9):e72033.
   PubMed Web of Science ®Google Scholar
• Ahn KS, Sethi G, Chaturvedi MM, Aggarwal BB. Simvastatin, 3‐hydroxy‐3‐methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor‐κB ligand through modulation of NF‐κB pathway. Int J Cancer 2008;123(8):1733–1740.
   PubMed Web of Science ®Google Scholar
• Thysell E, Surowiec I, Hörnberg E, Crnalic S, Widmark A, Johansson AI, et al. Metabolomic characterization of human prostate cancer bone metastases reveals increased levels of cholesterol. PloS ONE 2010;5(12):e14175.
   PubMed Web of Science ®Google Scholar
• Nelson ER, Wardell SE, Jasper JS, Park S, Suchindran S, Howe MK, et al. 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology. Science 2013;342(6162):1094–1098.
   PubMed Web of Science ®Google Scholar